Chemistry

Biotechs do deal: Eviagenics divests flavonoid technology

Biotechs do deal: Eviagenics divests flavonoid technology

By Lynda Searby

French biotech firm Alderys has bought Eviagenics’ micro-organism based flavonoid production platform for an undisclosed sum. The deal will allow Alderys to commercialise the technology and Eviagenics to focus on its seaweed extracts venture.

Lonza profits rise

Lonza profits rise

Lonza, the Swiss fine chemicals company, has reported a 5.2 per
cent rise in net profits for the first half of the year to SFr161
million (€109m) after good performances from all its main operating
divisions.

Degussa divestments complete

Degussa divestments complete

German chemicals company Degussa has sold its Frankfurt/Main-based
biopharmaceutical company Zentaris to Canadian firm AEterna
Laboratories for approximately €50 million, the company said last
week. The move marks the much-talked...

Spotlight

Follow us

Products

View more

Webinars

Featured Suppliers

All suppliers